Lombard aims to raise £25m

AIM-listed Lombard Medical Technologies said yesterday it plans to raise up to £25.3m through a placing organised by Evolution Securities and Eden Financial. Lombard will use the money to fund the launch and regulatory approval of Aorfix, a stent graft that avoids the need for surgery.